Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry

被引:10
|
作者
Corica, Bernadette [1 ,2 ,3 ]
Romiti, Giulio Francesco [1 ,2 ,3 ]
Proietti, Marco [1 ,2 ,4 ,5 ]
Mei, Davide Antonio [1 ,2 ,6 ]
Boriani, Giuseppe [6 ]
Chao, Tze-Fan [7 ,8 ,9 ]
Olshansky, Brian [10 ]
V. Huisman, Menno [11 ]
Lip, Gregory Y. H. [12 ,13 ]
机构
[1] Univ Liverpool, Liverpool John Moores Univ, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[2] Liverpool Heart & Chest Hosp, Liverpool, England
[3] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[5] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[6] Univ Modena & Reggio Emilia, Cardiol Div, Dept Biomed Metab & Neural Sci, Policlin Modena, Modena, Italy
[7] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[9] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[10] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiol, Iowa City, IA USA
[11] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands
[12] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[13] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg,6 W Derby St, Liverpool L7 8TX, England
关键词
BODY-MASS INDEX; WEIGHT; MANAGEMENT; RISK; ASSOCIATION; PREVENTION; REDUCTION; MORTALITY; PARADOX; DISEASE;
D O I
10.1016/j.mayocp.2023.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF). Methods: The global, prospective GLORIA-AF Registry Phase II and III included patients with recent diagnosis of AF between November 2011 and December 2014 for Phase II and between January 2014 and December 2016 for Phase III. With this analysis, we categorized patients with AF according to BMI (normal weight [18.5 to 24.9 kg/m2], overweight [25.0 to 29.9 kg/m2], obese [30.0 to 60.0 kg/m2]) and metabolic status (presence of hypertension, diabetes, and hyperlipidemia). We analyzed risk of major outcomes using multivariable Cox regression analyses; the primary outcome was the composite of all-cause death and major adverse cardiovascular events. Results: There were 24,828 (mean age, 70.1 +/- 10.3 years; 44.6% female) patients with AF included. Higher BMI was associated with metabolically unhealthy status and higher odds of receiving oral anticoagulants and other treatments. Normal-weight unhealthy patients showed a higher risk of the primary composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.01 to 1.42) and thromboembolism, whereas a lower risk of cardiovascular death (aHR, 0.35; 95% CI, 0.14 to 0.88) and major adverse cardiovascular events (aHR, 0.56; 95% CI, 0.33 to 0.93) was observed in metabolically healthy obese individuals. Unhealthy metabolic groups were also associated with increased risk of major bleeding (aHR, 1.51 [95% CI, 1.04 to 2.20] and aHR, 1.96 [95% CI, 1.34 to 2.85] in overweight and Conclusion: Increasing BMI was associated with poor metabolic status and with more intensive treatment. Prognosis was heterogeneous between BMI groups, with metabolically unhealthy patients showing higher risk of adverse events. (c) 2023 THE AUTHORS. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research. This is an open access article under
引用
收藏
页码:927 / 939
页数:13
相关论文
共 50 条
  • [31] Clinical outcomes of Asian patients with newly diagnosed atrial fibrillation and previously diagnosed atrial fibrillation: Insights from the CODE-AF Registry
    Choi, Jungmin
    Lee, So-Ryoung
    Kim, Tae-Hoon
    Yu, Hee Tae
    Park, Junbeom
    Park, Jin-Kyu
    Kang, Ki-Woon
    Shim, Jaemin
    Uhm, Jae-Sun
    Kim, Jun
    Park, Hyung Wook
    Kim, Jin-Bae
    Lee, Young Soo
    Joung, Boyoung
    Choi, Eue-Keun
    HEART RHYTHM, 2025, 22 (02) : 424 - 431
  • [32] Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry
    Bergler-Klein, Jutta
    Gotcheva, Nina
    Kalejs, Oskars
    Kalarus, Zbigniew
    Kovacic, Dragan
    Persic, Viktor
    Shlyakhto, Evgeny
    Uuetoa, Tiina
    Huisman, Menno V.
    Lip, Gregory Y. H.
    Vinereanu, Dragos
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (01) : e1 - e12
  • [33] Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
    Ding, Wern Yew
    Fawzy, Ameenathul Mazaya
    Romiti, Giulio Francesco
    Proietti, Marco
    Pastori, Daniele
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (01) : 39 - 49
  • [34] Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)
    Vemulapalli, Sreekanth
    Inohara, Taku
    Kim, Sunghee
    Thomas, Laine
    Piccini, Jonathan P.
    Patel, Manesh R.
    Chang, Paul
    Fonarow, Gregg C.
    Ezekowitz, Michael D.
    Hylek, Elaine
    Go, Alan S.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Gersh, Bernard J.
    Peterson, Eric D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (10) : 1628 - 1636
  • [35] Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
    Krittayaphong, Rungroj
    Pumprueg, Satchana
    Ratanasumawong, Kasem
    Sairat, Poom
    Lip, Gregory Y. H.
    CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 1835 - 1846
  • [36] Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase
    Proietti, Marco
    Laroche, Cecile
    Nyvad, Ole
    Haberka, Maciej
    Vassilikos, Vassilios P.
    Maggioni, Aldo P.
    Boriani, Giuseppe
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 166 - 172
  • [37] Increased mortality in patients with secondary diagnosis of atrial fibrillation: Report from Chinese AF registry
    Shao, Xing-Hui
    Yang, Yan-Min
    Zhu, Jun
    Yu, Li-Tian
    Liu, Li-Sheng
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2020, 25 (05)
  • [38] Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry
    Krittayaphong, Rungroj
    Boonyapiphat, Thanita
    Wongvipaporn, Chaiyasith
    Sairat, Poom
    CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 707 - 719
  • [39] Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
    Koziel, Monika
    Mazurek, Michal
    Teutsch, Christine
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang-Sheng
    Rothman, Kenneth J.
    Brandes, Axel
    Paquette, Miney
    Zint, Kristina
    Franca, Lionel Riou
    Lu, Shihai
    Bartels, Dorothee B.
    Huisman, Menno V.
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 11
  • [40] Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry
    Sani, Mahmoud U.
    Davison, Beth A.
    Cotter, Gad
    Mayosi, Bongani M.
    Edwards, Christopher
    Ogah, Okechukwu S.
    Damasceno, Albertino
    Ojji, Dike B.
    Dzudie, Anastase
    Mondo, Charles
    Kouam, Charles Kouam
    Suliman, Ahmed
    Yonga, Gerald
    Ba, Serigne Abdou
    Maru, Fikru
    Alemayehu, Bekele
    Sliwa, Karen
    CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 (03) : 139 - 145